Antibiotic Therapy in Infections of the Diabetic Foot Syndrome
NCT ID: NCT05616351
Last Updated: 2024-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2022-10-12
2023-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It analyses the implementation of the hospital in-house guidelines published in 2019 with regard to antibiotic therapy in diabetic foot infections, taking into account clinical, microbiological and histopathological criteria. The defined endpoints are (i) fully compliant with internal policies, (ii) partially compliant with internal policies, and (iii) not compliant with internal policies. The recording of these proportions is descriptive.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimal Antibiotics for Operated Diabetic Foot Infections
NCT04081792
Less Infections for the Diabetic Foot
NCT03615807
Effectiveness and Safety of Antibiotherapy in Diabetic Patients Treated for a Diabetic Foot Infection.
NCT03495349
Outcomes of Non-infected Diabetic Foot Ulcers With/Without Antibiotics
NCT01418456
Evaluating the Healing of Diabetic Foot Ulcers With Compounded Anti-Infective Irrigation Therapy
NCT05076955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Inadequate use of antibiotics should thus be recognized. The study has the aspect of quality control.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection in patients with diabetic foot syndrome and infections in the area of the foot
Data collection: on (surgical and antibiotic) treatment and implementation of the recommendations published 2019 with regard to the duration of antibiotic therapy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* inpatient stay at the University Hospital Basel between January 1st, 2019 and December 31st, 2021
* surgical intervention (amputation and/or debridement)
* signed general consent
Exclusion Criteria
* no surgical intervention performed (amputation and/or debridement)
* surgical interventions performed by disciplines other than orthopaedics/traumatology (e.g. vascular surgery)
* infections in osteosynthesis material (implant or fracture-associated infections)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Marc Müller, Prof. Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Department of Orthopaedics and Traumatology, University Hospital Basel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Basel, Orthopedics and Traumatology
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Reinert N, Wetzel K, Franzeck F, Morgenstern M, Aschwanden M, Wolff T, Clauss M, Sendi P. What is the agreement between principles and practice of antibiotic stewardship in the management of diabetic foot infection: an in-hospital quality control study. J Bone Jt Infect. 2024 Jun 28;9(3):183-190. doi: 10.5194/jbji-9-183-2024. eCollection 2024.
Related Links
Access external resources that provide additional context or updates about the study.
Link to citation
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-01512; mu22Mueller2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.